Survey of vaccine administration to splenectomized patients: Are guidelines being followed?

Autor Kew, Andrea K, White, Darrell, Slayter, Kathryn
Vydáno 2008

The Influence of Plaintiff’s Body Weight on Judgments of Responsibility: The Role of Weight Bias

Autor White, Darrell E., Wott, Carissa B., Carels, Robert A.
Vydáno v Obes Res Clin Pract (2013)

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

Autor White, Darrell E, Zhao, Yang, Jayapalan, Hemalatha, Machiraju, Pattabhi, Periyasamy, Ramu, Ogundele, Abayomi
Vydáno v Clin Ophthalmol (2020)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease

Autor White, Darrell E, Zhao, Yang, Jayapalan, Hemalatha, Machiraju, Pattabhi, Periyasamy, Ramu, Ogundele, Abayomi
Vydáno v Clin Ophthalmol (2020)

Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma

Autor Reece, Donna, Song, Kevin, LeBlanc, Richard, Mezzi, Khalid, Olujohungbe, Ade, White, Darrell, Zaman, Faraz, Belch, Andrew
Vydáno 2013

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

Autor White, Darrell E, Zhao, Yang, Ogundele, Abayomi, Fulcher, Nicole, Acs, Annabel, Moore-Schiltz, Laura, Karpecki, Paul M
Vydáno v Clin Ophthalmol (2019)

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Autor Quach, Hang, White, Darrell, Spencer, Andrew, Ho, P. Joy, Bhutani, Divaya, White, Mike, Inamdar, Sandeep, Morris, Chris, Ou, Ying, Gyger, Martin
Vydáno v Cancer Chemother Pharmacol (2017)

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Autor Dimopoulos, Meletios, Siegel, David, White, Darrell J., Boccia, Ralph, Iskander, Karim S., Yang, Zhao, Kimball, Amy S., Mezzi, Khalid, Ludwig, Heinz, Niesvizky, Ruben
Vydáno v Blood (2019)

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

Autor Yeu, Elizabeth, Goldberg, Damien F, Mah, Francis S, Beckman, Kenneth A, Luchs, Jodi I, Solomon, Jonathan D, White, Darrell E, Gupta, Preeya K
Vydáno v Clin Ophthalmol (2019)

Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

Autor Belch, Andrew, Bahlis, Nizar, White, Darrell, Cheung, Matthew, Chen, Christine, Shustik, Chaim, Song, Kevin, Tosikyan, Axel, Dispenzieri, Angela, Anderson, Kenneth, Brown, Diane, Robinson, Suzanne, Srinivasan, Shankar, Facon, Thierry
Vydáno v Cancer Med (2020)

Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-esc...

Autor Richardson, Paul G, Jagannath, Sundar, Moreau, Philippe, Jakubowiak, Andrzej J, Raab, Marc S, Facon, Thierry, Vij, Ravi, White, Darrell, Reece, Donna E, Benboubker, Lotfi, Zonder, Jeffrey, Tsao, L Claire, Anderson, Kenneth C, Bleickardt, Eric, Singhal, Anil K, Lonial, Sagar
Vydáno v Lancet Haematol (2015)

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma

Autor Bahlis, Nizar J., Sutherland, Heather, White, Darrell, Sebag, Michael, Lentzsch, Suzanne, Kotb, Rami, Venner, Christopher P., Gasparetto, Cristina, Del Col, Aldo, Neri, Paola, Reece, Donna, Kauffman, Michael, Shacham, Sharon, Unger, T. J., Jeha, Jacqueline, Saint-Martin, Jean-Richard, Shah, Jatin, Chen, Christine
Vydáno v Blood (2018)

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database

Autor Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.
Vydáno v Haematologica (2020)

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

Autor Dimopoulos, Meletios, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, San-Miguel, Jesus, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Srinivasan, Shankar, Yu, Xin, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul
Vydáno v Leukemia (2020)

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

Autor Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus
Vydáno v Leukemia (2020)

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth...

Autor Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San‐Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter‐Croneck, Adam, Magen, Hila, Mateos, Maria‐Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Bleickardt, Eric, Poulart, Valerie, Sheng, Jennifer, Sy, Oumar, Katz, Jessica, Singhal, Anil, Richardson, Paul
Vydáno v Br J Haematol (2017)

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of C...

Autor Stewart, A. Keith, Trudel, Suzanne, Bahlis, Nizar J., White, Darrell, Sabry, Waleed, Belch, Andrew, Reiman, Tony, Roy, Jean, Shustik, Chaim, Kovacs, Michael J., Rubinger, Morel, Cantin, Guy, Song, Kevin, Tompkins, Kirsty A., Marcellus, Deb C., Lacy, Martha Q., Sussman, Jonathan, Reece, Donna, Brundage, Michael, Harnett, Erica L., Shepherd, Lois, Chapman, Judy-Anne W., Meyer, Ralph M.
Vydáno 2013

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Autor Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Weisel, Katja, San-Miguel, Jesus, Shpilberg, Ofer, Grosicki, Sebastian, Špička, Ivan, Walter-Croneck, Adam, Magen, Hila, Mateos, Maria-Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z., Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Matsumoto, Morio, Wu, Ka Lung, Anderson, Kenneth C., Jou, Ying-Ming, Ganetsky, Alex, Singhal, Anil K., Richardson, Paul G.
Vydáno v Blood Cancer J (2020)

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX

Autor Kaufman, Jonathan L., Dimopoulos, Meletios A., White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Joy Ho, P., Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Sutherland, Heather J., Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Miles Prince, H., Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J., Chari, Ajai, O’Rourke, Lisa, Trivedi, Sonali, Casneuf, Tineke, Krevvata, Maria, Ukropec, Jon, Kobos, Rachel, Avet-Loiseau, Hervé, Usmani, Saad Z., San-Miguel, Jesus
Vydáno v Blood Cancer J (2020)

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX

Autor Dimopoulos, Meletios A., San-Miguel, Jesus, Belch, Andrew, White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Sutherland, Heather J., Lalancette, Marc, Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Prince, H. Miles, Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J., Chari, Ajai, O’Rourke, Lisa, Wu, Kaida, Schecter, Jordan M., Casneuf, Tineke, Chiu, Christopher, Soong, David, Sasser, A. Kate, Khokhar, Nushmia Z., Avet-Loisea, Hervé, Usmani, Saad Z.
Vydáno v Haematologica (2018)